(19)
(11) EP 2 255 189 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
06.05.2015 Bulletin 2015/19

(45) Mention of the grant of the patent:
31.12.2014 Bulletin 2015/01

(21) Application number: 09709027.8

(22) Date of filing: 09.02.2009
(51) International Patent Classification (IPC): 
C12N 5/16(2006.01)
 A61P 11/06(2006.01)
(86) International application number:
PCT/US2009/033581
(87) International publication number:
WO 2009/100445 (13.08.2009 Gazette 2009/33)

(54)

COMPOSITIONS AND METHODS WHICH MODULATE G-PROTEIN SIGNALING FOR THE TREATMENT OF ASTHMA

ZUSAMMENSETZUNGEN UND VERFAHREN, DIE DIE G-PROTEIN-SIGNALGEBUNG MODULIEREN, ZUR BEHANDLUNG VON ASTHMA

COMPOSITIONS ET MÉTHODES MODULANT LE SIGNALEMENT DE LA PROTÉINE-G DANS LE TRAITEMENT DE L ASTHME

(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK TR

(30) Priority: 07.02.2008 US 26915 P

(43) Date of publication of application:
01.12.2010 Bulletin 2010/48

(73) Proprietor: Grunstein, Michael M.
Merion Station, PA 19066 (US)

(72) Inventor:
  • Grunstein, Michael M.
    Merion Station, PA 19066 (US)

(74) Representative: Potter Clarkson LLP 
The Belgrave Centre Talbot Street
Nottingham, NG1 5GG
Nottingham, NG1 5GG (GB)


(56) References cited: : 
WO-A2-01/11933
US-A- 6 017 763
US-B1- 6 812 339
 WO-A2-97/49818
US-A1- 2006 115 813
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).